![PDF) POC052 Assessment of [131I]MIBG in Combination with DNA Repair Inhibitors for Neuroblastoma Therapy PDF) POC052 Assessment of [131I]MIBG in Combination with DNA Repair Inhibitors for Neuroblastoma Therapy](https://i1.rgstatic.net/publication/280715191_POC052_Assessment_of_131IMIBG_in_Combination_with_DNA_Repair_Inhibitors_for_Neuroblastoma_Therapy/links/55c2192108aebc967defd184/largepreview.png)
PDF) POC052 Assessment of [131I]MIBG in Combination with DNA Repair Inhibitors for Neuroblastoma Therapy
![N-CSR 1 filing788.htm PRIMARY DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES ... N-CSR 1 filing788.htm PRIMARY DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES ...](https://www.sec.gov/Archives/edgar/data/819118/000137949119005411/img543589499_740.jpg)
N-CSR 1 filing788.htm PRIMARY DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES ...
![Designer profile_vol 02 - Product design award-Dot design award-Communication design award | PubHTML5 Designer profile_vol 02 - Product design award-Dot design award-Communication design award | PubHTML5](https://online.pubhtml5.com/zhka/qyca/files/thumb/151.jpg?1568913106)